The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Pfizer Inc. (NYSE:PFE) is one of the

7 Best Longevity Stocks to Buy Now.

On June 8, 2026, Pfizer Inc. (NYSE:PFE) announced that the U.S. FDA approved an expanded indication for Hympavzi to include patients with hemophilia A or B 12 years and older with inhibitors and pediatric patients with or without inhibitors. Hympavzi is now indicated in the U.S. for routine prophylaxis to prevent or reduce bleeding episodes in adults and pediatric patients 6 years and older with hemophilia A with or without factor VIII inhibitors, or hemophilia B with or without factor IX inhibitors.

On June 7, 2026, Pfizer Inc. (NYSE:PFE) presented detailed Phase 2b results for berobenatide, an investigational monthly GLP-1 receptor agonist peptide, at the 86th Scientific Sessions of the American Diabetes Association. The company said the VESPER-1, 2, and 3 studies provided proof of concept for berobenatide as a potential first-in-class monthly GLP-1 RA peptide, showed favorable tolerability, and highlighted potential advantages from monthly delivery and a 0.5 mL injection volume.

On May 31, 2026, Pfizer Inc. (NYSE:PFE) announced detailed progression-free and overall survival results from Cohort 3 of the Phase 3 Breakwater trial. Pfizer said median progression-free survival was nearly doubled with the BRAFTOVI combination regimen versus the comparator.

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.